Keytruda

7 results

Pharma giant MSD has agreed to buy Takeda’s state-of-the-art biologics plant in Dunboyne, Co Meath, where around 200 workers are currently employed

Pharma giant MSD has agreed to buy a state-of-the-art biologics plant in Dunboyne, Co Meath, where around 200 workers are currently employed. The dea(...)

  Cancer patient Maria Waters requires a drug that is not licensed in the State for the treatment of   head and neck cancer. Photograph:    Nick Bradshaw

The husband of a woman with stage four cancer has called on pharma company MSD to provide her with a €40,000 course of vital drugs on compassionate gr(...)

 Maria Waters: she  has been advised by three consultants that Pembro is the best course of treatment for her cancer. Photograph: Nick Bradshaw

The husband of a cancer patient has written to Irish medicines regulators urging them to act quickly on approving a drug that will treat her head and (...)

Ger Brennan, who trained as a nurse, was keen to merge his medical interest with sales. After ‘a hundred PFOs’ applying to be a medical rep he landed a contract job with Bayer

Brexit doesn’t worry Ger Brennan. It’s a startling take from an industry leader, given how much the relentless uncertainty over the manner of the even(...)

Merck’s cancer drug Keytruda booked sales of more than $2 billion for the first time in the fourth quarter. Photograph: Brendan McDermid/Reuters

Merck’s cancer immumotherapy Keytruda booked sales of more than $2 billion in a quarter for the first time, exceeding Wall Street’s lofty estimates an(...)

Even though they are exported from Ireland for use in other European countries, five drugs manufactured in Ireland for the treatment of cancer and heart disease are not sanctioned for use here.

Five drugs manufactured in Ireland for the treatment of cancer and heart disease are not sanctioned for use here, even though they are exported from I(...)

Merck reported a better-than-expected first-quarter profit on Tuesday, helped by a rise of more than 150 per cent in sales of cancer drug Keytruda.

Drugmaker Merck reported a better-than-expected first-quarter profit on Tuesday, helped by a rise of more than 150 per cent in sales of cancer drug Ke(...)